Concepedia

Andrew J. Aschenbrenner

AJ

55

Publications

2.4K

Citations

26

H-Index

2012

Active since

Affiliations

Washington University in St. Louis(Current)

Hope Center for Neurological Disorders

University College London

German Center for Neurodegenerative Diseases

The University of Melbourne

Andrew J. Aschenbrenner is an author at Washington University in St. Louis specializing in cognitive science, social sciences, and cognition.

ORCID

Top concepts

Publications per year

2012–2025

55

Publications

55

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 349 citations · Full text

, , +9

Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease

Andrew J. Aschenbrenner, Brian A. Gordon, Tammie L.S. Benzinger et al. · Neurology · 2018 · 275 citations · Full text

Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers

Brian A. Gordon, Tyler Blazey, Jon Christensen et al. · Brain · 2019 · 173 citations · Full text

, , +20

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

Gemma Salvadó, Kanta Horie, Nicolas R. Barthélemy et al. · Nature Aging · 2024 · 100 citations · Full text

Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer’s disease

Jessica Nicosia, Andrew J. Aschenbrenner, David A. Balota et al. · Journal of the International Neuropsychological Society · 2022 · 92 citations · Full text

Rows per page

1–5 of 55